The Gross Law Firm issues the following notice to shareholders ofModerna, Inc. (NASDAQ: MRNA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MRNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Moderna Loss Submission […]

The Gross Law Firm issues the following notice to shareholders of GitLab Inc. (NASDAQ: GTLB). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of GTLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: GitLab Loss

The Gross Law Firm issues the following notice to shareholders ofMacroGenics, Inc. (NASDAQ: MGNX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MGNX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: MacroGenics, Inc. Loss

The Gross Law Firm issues the following notice to shareholders ofVicor Corporation (NASDAQ: VICR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of VICR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Vicor Corporation Loss

The Gross Law Firm issues the following notice to shareholders ofSage Therapeutics, Inc. (NASDAQ: SAGE). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SAGE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Sage Therapeutics

The Gross Law Firm issues the following notice to shareholders ofDexCom, Inc. (NASDAQ: DXCM). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: DexCom, Inc. Loss

The Gross Law Firm issues the following notice to shareholders of Sprinklr, Inc. (NYSE: CXM). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of CXM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Sprinklr Loss

The Gross Law Firm issues the following notice to shareholders of Methode Electronics, Inc. (NYSE: MEI). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MEI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Methode

The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Orthofix

The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Orthofix